Press release

25 May 2017

WISE raises EUR 6.5 million for clinical validation of novel neuroelectrodes for brain monitoring and spinal cord stimulation

Minimally invasive, highly conformable, foldable and stretchable electrodes
for growing Neuromonitoring and Neuromodulation markets being developed

 

Milan, Italy and Berlin, Germany, 25th May 2017 - WISE Srl, a medical device company developing next-generation implantable neuromodulation leads announces today the closing of a EUR 6.5 million series B financing round, led by Principia SGR, an Italian Venture Capital firm. Existing investors Atlante Ventures, High-Tech Gründerfonds, F3F and Antares joined the round.

WISE develops novel, highly flexible and stretchable implantable neuromodulation leads for the treatment of a range of neurological conditions based on its proprietary Supersonic Cluster Beam Implantation (SCBI) technology. By means of the new financial round, WISE aims to market its first product for acute use, Cortical Electrodes for intraoperative monitoring, and to conclude the development of its breakthrough product, the first percutaneously-implantable paddle lead for Spinal Cord Stimulation (SCS).

WISE’s paddles will be foldable, therefore combining the strengths of paddle leads - directional stimulation and precise selection of the stimulation point - with the versatility, simple positioning and easy removal of percutaneous leads. WISE’s Foldable SCS Paddle Leads have the mission to overcome today’s trade-off between leads’ performance and invasiveness of the surgery. Having established in 2016 its 1000 m2 manufacturing plant in Cologno Monzese (Milan, Italy), which comprises equipment and cleanrooms compliant for the production of implantable medical devices, WISE is currently CE marking the Cortical Electrodes and developing the Foldable SCS Paddle Leads.

09 Jun 2015

WISE S.r.l. raises EUR 3 million for clinical development of novel neuromodulation implants for spinal cord stimulation

Foldable and stretchable electrodes for growing neuromodulation market being developed

Milan, Italy and Berlin, Germany, 9th June 2015 - WISE Srl, a medical device company developing next-generation implantable neuromodulation leads announces today the closing of a EUR 3 million series A financing round, led by Principia SGR, an Italian Venture Capital firm. Existing investors High-Tech Gründerfonds, Atlante Seed and b-to-v Partners joined the round alongside with three new investors Atlante Ventures, F3F and Antares.


Download PDF

09 Jun 2015

WISE S.r.l. raccoglie 3 milioni di euro per lo sviluppo clinico di nuovi elettrodi per la stimolazione spinale

WISE sta sviluppando la prossima generazione di elettrodi ripieghevoli ed elastici per il mercato della neuromodulazione

Milano, Italia e Berlino, Germania, 9 giugno 2015 - WISE Srl, società biomedicale che sta sviluppando la prossima generazione di elettrodi impiantabili per neuromodulazione, ha chiuso un round d’investimento da 3 milioni di euro guidato dal fondo italiano di venture capital Principia SGR. Hanno partecipato al round d’investimento anche i fondi Atlante Ventures, F3F e Antares, oltre agli attuali soci High-Tech Gründerfonds, Atlante Seed e b-to-v Partners.


Download PDF

31 Dec 2014

Press Review 2014

The list of the most significant press articles published about WISE in 2014.


Download PDF

31 Dec 2013

Press Review 2013

The list of the most significant press articles published about WISE in 2013.


Download PDF

20 Nov 2013

Capitali italiani, tedeschi e svizzeri per la start-upbiomedicale WISE Srl.

WISE (Wiringless Implantable Stretchable Electronics), startup italiana fondata nel 2011 da quattro ricercatori provenienti dall'Università di Milano e dal fondo Agite!, ha chiuso un round di investimento da 1 milione di euro al quale hanno preso parte il fondo italiano Atlante Seed, il fondo tedesco High-Tech Gründerfonds (HTGF) e la società di investimento svizzera b-to-v Partners, oltre agli attuali soci Agite! e Veneto Nanotech. La società sta sviluppando, mediante una tecnologia innovativa proprietaria, la prossima generazione di elettrodi impiantabili per neurostimolazione e utilizzerà l'investimento ottenuto per proseguire lo sviluppo del suo primo prodotto destinato alla stimolazione del midollo spinale.

07 Nov 2013

WISE raises € 1 M in equity financing

WISE s.r.l. raises € 1 M in equity financing to Develop Next-Generation Neurostimulation Devices

WISE (Wiringless Implantable Stretchable Electronics), a Milan- and Berlin-based medical device company is developing next-generation implantable neurostimulation devices based on their unique and proprietary technology platform. The company has now raised a seed-round of € 1 M to advance the development of its first product aimed at the spinal cord stimulation market. High-Tech Gründerfonds, Atlante Seeds and b-to-v Partners co-led the round and were joined by the existing investor Agite!.

31 Dec 2012

Press Review 2012

The list of the most significant press articles published about WISE in 2012.


Download PDF

31 Dec 2011

Press Review 2011

The list of the most significant press articles published about WISE in 2011.


Download PDF